Fall from Grace
Drug maker Johnson & Johnson agreed to pay $2.2 billion and plead guilty to a misdemeanor in marketing the antipsychotic drug Risperdal and other drugs. “The agreement,” The New York Times writes (Nov. 4), “is the third-largest pharmaceutical settlement in United States history and the largest in a string of recent cases involving the marketing of antipsychotic and anti-seizure drugs to older...
November 6, 2013